[{"address1": "10628 Science Center Drive", "address2": "Suite 250", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "858 900 2660", "website": "https://arcturusrx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Arcturus Therapeutics Holdings Inc. engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms includes LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate that is in phase 2 clinical trial for cystic fibrosis. Its product pipeline includes KOSTAIVE for the treatment of covid 19; ARCT-2138 (LUNAR-FLU), which is in phase 1 clinical trial for the treatment of seasonal influenza; ARCT-2304 (LUNAR-H5N1) that is in phase 1 clinical trial for the treatment of Pandemic Influenza; ARCT-2301 for bivalent: ancestral/omicron which is in Phase 3 clinical trial; and ARCT-2303 for monovalent that is in Phase 3 clinical trial. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.", "fullTimeEmployees": 174, "companyOfficers": [{"maxAge": 1, "name": "Mr. Joseph E. Payne M.Sc.", "age": 52, "title": "Founder, President, CEO & Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 1062000, "exercisedValue": 0, "unexercisedValue": 2086450}, {"maxAge": 1, "name": "Dr. Padmanabh  Chivukula Ph.D.", "age": 45, "title": "Founder, Chief Scientific Officer, COO & Secretary", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 778000, "exercisedValue": 0, "unexercisedValue": 1370925}, {"maxAge": 1, "name": "Mr. Andrew H. Sassine MBA", "age": 60, "title": "CFO & Director", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 811000, "exercisedValue": 0, "unexercisedValue": 1901388}, {"maxAge": 1, "name": "Mr. Lance  Kurata", "title": "Chief Legal Officer", "fiscalYear": 2024, "totalPay": 680000, "exercisedValue": 0, "unexercisedValue": 3125}, {"maxAge": 1, "name": "Ms. Neda  Safarzadeh", "title": "Vice President and Head of IR/PR & Marketing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Natasha O. Bowman", "title": "Chief Human Resources Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin T. Skol", "title": "Chief Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Juergen  Froehlich FCPh, M.D., MBA", "age": 68, "title": "Chief Medical Officer", "yearBorn": 1956, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Igor  Smolenov M.D., Ph.D.", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Roberta  Duncan", "title": "Chief Strategy Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 3, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 6, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 11.64, "open": 11.68, "dayLow": 11.4151, "dayHigh": 11.88, "regularMarketPreviousClose": 11.64, "regularMarketOpen": 11.68, "regularMarketDayLow": 11.4151, "regularMarketDayHigh": 11.88, "payoutRatio": 0.0, "beta": 2.368, "forwardPE": -5.224215, "volume": 335676, "regularMarketVolume": 335676, "averageVolume": 434351, "averageVolume10days": 468850, "averageDailyVolume10Day": 468850, "bid": 8.54, "ask": 14.92, "bidSize": 2, "askSize": 2, "marketCap": 315954976, "fiftyTwoWeekLow": 8.04, "fiftyTwoWeekHigh": 45.0, "priceToSalesTrailing12Months": 2.1990185, "fiftyDayAverage": 11.8782, "twoHundredDayAverage": 17.09235, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 141665024, "profitMargins": -0.47467, "floatShares": 24984584, "sharesOutstanding": 27120600, "sharesShort": 5136524, "sharesShortPriorMonth": 4647257, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.1894, "heldPercentInsiders": 0.07887, "heldPercentInstitutions": 0.92541003, "shortRatio": 11.21, "shortPercentOfFloat": 0.2967, "impliedSharesOutstanding": 27120600, "bookValue": 8.619, "priceToBook": 1.3516648, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -68200000, "trailingEps": -2.52, "forwardEps": -2.23, "lastSplitFactor": "1:7", "lastSplitDate": 1510790400, "enterpriseToRevenue": 0.986, "enterpriseToEbitda": -1.801, "52WeekChange": -0.61836064, "SandP52WeekChange": 0.11469197, "quoteType": "EQUITY", "currentPrice": 11.65, "targetHighPrice": 140.0, "targetLowPrice": 44.0, "targetMeanPrice": 69.601, "targetMedianPrice": 61.5, "recommendationMean": 1.27273, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 10, "totalCash": 216948000, "totalCashPerShare": 7.999, "ebitda": -78642000, "totalDebt": 42658000, "quickRatio": 4.686, "currentRatio": 5.643, "totalRevenue": 143680000, "debtToEquity": 18.249, "revenuePerShare": 5.31, "returnOnAssets": -0.13668999, "returnOnEquity": -0.27403998, "grossProfits": -32796000, "freeCashflow": -53719876, "operatingCashflow": -89328000, "revenueGrowth": -0.227, "grossMargins": -0.22826, "ebitdaMargins": -0.54734004, "operatingMargins": -0.57265997, "financialCurrency": "USD", "symbol": "ARCT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 0.08590443, "regularMarketPrice": 11.65, "corporateActions": [], "postMarketTime": 1747435823, "regularMarketTime": 1747425601, "longName": "Arcturus Therapeutics Holdings Inc.", "shortName": "Arcturus Therapeutics Holdings ", "regularMarketChange": 0.009999275, "regularMarketDayRange": "11.4151 - 11.88", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 434351, "fiftyTwoWeekLowChange": 3.6099997, "fiftyTwoWeekLowChangePercent": 0.44900495, "fiftyTwoWeekRange": "8.04 - 45.0", "fiftyTwoWeekHighChange": -33.35, "fiftyTwoWeekHighChangePercent": -0.7411111, "fiftyTwoWeekChangePercent": -61.836063, "dividendDate": 1510790400, "earningsTimestamp": 1747080060, "earningsTimestampStart": 1754305140, "earningsTimestampEnd": 1754654400, "earningsCallTimestampStart": 1747081800, "earningsCallTimestampEnd": 1747081800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.52, "epsForward": -2.23, "epsCurrentYear": -3.22286, "priceEpsCurrentYear": -3.6148016, "fiftyDayAverageChange": -0.22819996, "fiftyDayAverageChangePercent": -0.019211663, "twoHundredDayAverageChange": -5.4423504, "twoHundredDayAverageChangePercent": -0.31840855, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1369229400000, "postMarketChange": -0.25, "postMarketChangePercent": -2.14592, "postMarketPrice": 11.4, "exchange": "NGM", "messageBoardId": "finmb_235062181", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "displayName": "Arcturus Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-17"}]